Skip to main content

Remote Job Finders (RJF)

‘Pharma bro’ Shkreli runs afoul of court’s lifetime pharma ban

Since his release from prison in 2022, Martin Shkreli has traded stocks and publicly opined on news events, damaging reputations and sinking share prices for small biotechs including Capricor and Cassava, the FTC alleges.

Pfizer pens $500M+ deal with Enodia to destroy disease-causing proteins

After Pfizer’s venture arm co-led Enodia Therapeutics’ $25 million seed round in January, the pharma has signed up to collaborate with the biotech on small-molecule drugs to eliminate pathogenic proteins where they’re being made.

GSK pledges $800M to add biologics production capabilities in Pennsylvania

Starting next year, GSK plans to demolish existing buildings and construct new facilities to support clinical and commercial supply. The investment will create more than 300 new jobs over the next five years, Pennsylvania state officials said.
Scroll to top